Iron Triangle Partners »

Eli Lilly & Co. shares owned by Iron Triangle Partners

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Iron Triangle Partners from 13F filings

Historical chart of Iron Triangle Partners investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Iron Triangle Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Iron Triangle Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $38M 50k 763.00

More positions owned by Iron Triangle Partners

CVS Caremark Corporation (CVS)
Dex (DXCM)
Abbvie (ABBV)
Medtronic SHS (MDT)
Charles River Laboratories (CRL)
Eli Lilly & Co. (LLY)
Brightspring Health Svcs (BTSG)
Repligen Corporation (RGEN)
Glaukos (GKOS)
Tenet Healthcare Corp Com New (THC)
EXACT Sciences Corporation (EXAS)
Adaptive Biotechnologies Cor (ADPT)
Madrigal Pharmaceuticals (MDGL)
Guardant Health (GH)
Brookdale Senior Living (BKD)

View all positions for Iron Triangle Partners

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
Capital Research Global Investors
FMR
Geode Capital Management
Capital World Investors
Morgan Stanley
Wellington Management Company
State Farm Mutual Automobile Insurance Company
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3

View all funds holding Eli Lilly & Co.